A small molecule inhibitor of Rheb selectively targets mTORC1 signaling
Aberrant mTORC1 signaling is linked to several chronic diseases. Here, the authors develop a small molecule inhibitor that binds the small G-protein Rheb and selectively blocks mTORC1 signaling, holding potential for therapeutic applications.
Guardado en:
Autores principales: | Sarah J. Mahoney, Sridhar Narayan, Lisa Molz, Lauren A. Berstler, Seong A. Kang, George P. Vlasuk, Eddine Saiah |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e4e93d6c676242c793f6e0e9b9280186 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.
por: Morris E Feldman, et al.
Publicado: (2009) -
mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation
por: Xiaolei Ding, et al.
Publicado: (2016) -
Crosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function
por: Fangjie Wang, et al.
Publicado: (2018) -
Differential controls of MAIT cell effector polarization by mTORC1/mTORC2 via integrating cytokine and costimulatory signals
por: Huishan Tao, et al.
Publicado: (2021) -
mTORC1 accelerates retinal development via the immunoproteasome
por: Ji-Heon Choi, et al.
Publicado: (2018)